UroGen Pharma Ltd (URGN) — Capital Reinvestment Ratio
Latest as of September 2017:
0.01x
UroGen Pharma Ltd (URGN) has a Capital Reinvestment Ratio of 0.01x as of September 2017, meaning it reinvests 0% of its operating cash flow ($2.60 Million) in capital expenditures ($20.00K). See URGN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$2.60 Million
USD
Capital Expenditures
$20.00K
USD
Data as of
Sep 2017
Most recent filing
UroGen Pharma Ltd Capital Reinvestment Ratio (2016–2016)
This chart tracks UroGen Pharma Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for UroGen Pharma Ltd (2016–2016)
Year-by-year Capital Reinvestment Ratio for UroGen Pharma Ltd from 2016 to 2016. For live market cap and broader valuation context, see UroGen Pharma Ltd (URGN) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $4.19 Million | $695.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow